antipyrine has been researched along with suprofen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Eggenschwiler, E; Novoselac, M; Tanner, K | 1 |
Michos, N; Stocker, H; Weippl, G | 1 |
2 trial(s) available for antipyrine and suprofen
Article | Year |
---|---|
[The analgesic effect of suprofen in hospitalized patients after tonsillectomy--a double-blind study after rectal administration].
Topics: Analgesics; Antipyrine; Barbiturates; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Humans; Phenylpropionates; Rectum; Suppositories; Suprofen; Tonsillectomy | 1985 |
Clinical experience and results of treatment with suprofen in pediatrics. 4th communication: Assessment of pain in babies and infants/Analgesic effect of suprofen syrup in otitis media.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Child, Preschool; Drug Combinations; Humans; Infant; Lidocaine; Otitis Media; Pain; Phenylpropionates; Solutions; Suprofen; Time Factors | 1985 |
3 other study(ies) available for antipyrine and suprofen
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |